Citrullination of proteins: a common posttranslational modification pathway induced by different nanoparticles in vitro and in vivoUpdate on carbon nanotube toxicityThe effects of carbon nanotubes on lung and dermal cellular behaviorsGold nanoprobes for theranosticsCaring for social complexity in nanomedicineAntimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugsNanoparticle-mediated drug delivery for treating melanomaClues for biomimetics from natural composite materialsVirus-like particles as antigenic nanomaterials for inducing protective immune responses in the lungBiomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imagingAdvances in molecular imaging: targeted optical contrast agents for cancer diagnosticsBench-to-bedside translation of magnetic nanoparticlesResponsive cell-material interfacesGold nanoparticles for photoacoustic imagingReactive oxygen species-activated nanomaterials as theranostic agentsCancer stem cells and drug resistance: the potential of nanomedicineNanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug deliveryEGF receptor-targeted nanocarriers for enhanced cancer treatmentNanomedicine delivers promising treatments for rheumatoid arthritisNanoengineering approaches to the design of artificial antigen-presenting cellsNanocarriers for vascular delivery of antioxidantsGadolinium-based nanoparticles for theranostic MRI-radiosensitizationMolecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agentsIron oxide-based nanostructures for MRI and magnetic hyperthermiaDelivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles.Functional interaction between charged nanoparticles and cardiac tissue: a new paradigm for cardiac arrhythmia?Endotoxin contamination: a key element in the interpretation of nanosafety studiesNanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosisThe impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug deliveryThe potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trialsCodelivery of salinomycin and doxorubicin using nanoliposomes for targeting both liver cancer cells and cancer stem cellsInhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activityEthics in nanomedicineNanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicineMaternal nanomaterial exposure: a double threat to maternal uterine health and fetal development?Experimental considerations on the cytotoxicity of nanoparticlesNanoparticles for imaging and treating brain cancerAssessing the impact of engineered nanoparticles on wound healing using a novel in vitro bioassayChemically activatable viral capsid functionalized for cancer targetingSilk fibroin-derived nanoparticles for biomedical applications.
P1433
Q23910338-69DDAA32-F8B2-4E59-8E3A-2449BDC5CBDBQ23919497-CB12D0E9-C046-47EC-A76A-0041D84D9513Q23921939-9DA1A650-5664-4521-BC94-CEF71A2C22AAQ24629197-90C0F0CB-CA2A-4D09-A6E4-7E2CC1F54093Q26786385-74143E37-2D54-48E4-9EAD-EFA4E2A3D7FDQ26797497-B31E4172-2B09-412A-9CF8-8679D1F3F5C1Q26798379-3C51D030-BA37-4430-B808-58E033020FC2Q26822747-DFB20366-8298-48FF-92F0-E46A465EA6FAQ26825031-0A4A8053-2B2D-45D4-8DE3-9C1E54431E99Q26827998-5B0C07D4-51A1-4316-97BB-D59BCAC07C50Q26829059-1E83B344-94C3-487C-BCFE-E9912899E7E9Q26850547-5B823506-FFB7-46A9-9606-7DB1271CCC02Q26851846-619F1FA0-B8D5-42CC-946A-97969D21C1CAQ26858831-82B52D45-6E18-4CB7-B992-23AD8CA921E1Q26865564-37993569-7F48-4FC2-A85C-F5E65C15D349Q26998993-14A9B8E9-61DD-4ADF-B511-A0421450D6E3Q27007119-81F51CEC-3B71-45BF-98C8-8A29DB35135EQ27013001-964F711B-5E56-4AA9-B017-D10496B7B317Q27021438-4DE7F540-C1AE-4CFB-8CA9-38586FC767CFQ27023634-0CECA371-18AC-47C7-BA93-ED267472E3E7Q27027067-70728624-C5C3-46E0-8CBD-3A7A81279D95Q27027308-0B474A8E-C6E8-41C9-B2D3-6D5DCDEDA14DQ27027613-DA7D88D3-03F3-42F4-B06D-B13DDB9E7776Q27027859-857B2639-9594-4DC7-9B1C-19C1E80BCEEDQ27335339-7DF3F1D7-F138-4315-AB68-99063E1E2DCAQ27335374-E8B77F0B-3A06-40FB-AD8C-3C3405909880Q28071776-36716CD2-5E57-43A6-A190-9CDC2AFCC01FQ28074991-9E46D208-7708-4CBA-B6A8-FD503BE01062Q28085280-C31A91F1-E70B-4DE4-A774-E0749162BB57Q28087336-7A748F5D-6567-410D-B6E7-13782692B8CCQ28315452-8D144832-DBFF-42F2-8403-8A73D59D18EDQ28386730-D55B287C-2DD5-4FD0-9A9F-9F1D909ECBD2Q28389241-2F3D1A85-DA55-44B2-9812-5543541B8B9AQ28390007-4D1CBF34-AE18-4ED6-800D-601EB46611D3Q28392063-20FB9083-1E41-4976-9754-A61618D9505BQ28392779-D48C0FBC-E19B-46F1-845E-3A70EA3F507CQ28394053-AA175ACD-5BCD-4104-983E-A14249C71D36Q28396728-04F91AF9-88EE-4DC6-BEBE-CB4D4669A09EQ28830058-DAE1554F-0C20-4F98-9178-A3B3639C11A4Q30156091-903ECEDE-7044-493C-8B2F-09D855F8EFF5
P1433
description
Medical journal
@en
Medical journal
@en-gb
Medizinische Fachzeitschrift
@de
Revue médicale
@fr
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Future Medicine
@nl
name
Nanomedicine
@ast
Nanomedicine
@da
Nanomedicine
@de
Nanomedicine
@en
Nanomedicine
@en-ca
Nanomedicine
@en-gb
Nanomedicine
@es
Nanomedicine
@fi
Nanomedicine
@fr
Nanomedicine
@it
type
label
Nanomedicine
@ast
Nanomedicine
@da
Nanomedicine
@de
Nanomedicine
@en
Nanomedicine
@en-ca
Nanomedicine
@en-gb
Nanomedicine
@es
Nanomedicine
@fi
Nanomedicine
@fr
Nanomedicine
@it
prefLabel
Nanomedicine
@ast
Nanomedicine
@da
Nanomedicine
@de
Nanomedicine
@en
Nanomedicine
@en-ca
Nanomedicine
@en-gb
Nanomedicine
@es
Nanomedicine
@fi
Nanomedicine
@fr
Nanomedicine
@it
P243
P3181
P101
P1055
P1058
P1156
6100152802
P1159
P1160
Nanomedicine
P123
P1250
P1277
P1476
Nanomedicine
@en
P236
P243
P3181
P407
P571
2006-01-01T00:00:00Z